Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

Covidien, a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan’s LAP-BAND® System, the top-selling adjustable gastric band for bariatric surgery, in the United States.

18 Jan 2010

MAGIC investigators identify new genetic variants that influence insulin and glucose regulation

An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.

18 Jan 2010

ASA urges patients to make lifestyle changes before opting for complicated surgeries

At a time of year when people make plans to drop a few pounds, perhaps even consider bariatric surgery, the American Society of Anesthesiologists (ASA) wants to ensure the public has the facts regarding one's weight and the impact it may have on his or her anesthesia experience.

18 Jan 2010

Researchers identify new gene variants associated With glucose, insulin levels

A major international study with leadership from Massachusetts General Hospital (MGH) researchers has identified 10 new gene variants associated with blood sugar or insulin levels. Two of these novel variants and three that earlier studies associated with glucose levels were also found to increase the risk of type 2 diabetes. Along with a related study from members of the same research consortium, associating additional genetic variants with the metabolic response to a sugary meal, the report will appear in Nature Genetics and has been released online.

18 Jan 2010

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

...

18 Jan 2010

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

A new evidence review suggests that using a pump to deliver insulin continuously — instead of taking three or more daily injections — might result in better control of blood sugar for people with type 1 diabetes.

18 Jan 2010

Researchers uncover novel genetic markers for diabetes-related traits

In two major studies published in Nature Genetics today, researchers use biological understanding to dissect the genetics of diabetes. An international team comprising researchers from more than 100 institutions analysed vast suites of genetic data from more than 100,000 people of European descent to uncover the associations.

18 Jan 2010

OSA adversely affects glucose control in patients with type 2 diabetes

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.

18 Jan 2010

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

The Juvenile Diabetes Research Foundation today announced an innovative partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease -- the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial pancreas, a fully automated system to dispense insulin to patients based on real-time changes in blood sugar levels.

18 Jan 2010

New analysis finds cost of diabetes and pre-diabetes reached $218 billion in 2007

A new analysis found that the cost of diabetes and pre-diabetes reached $218 billion in 2007, with the exploding number of cases of type 2 diabetes responsible for the majority of the costs. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis, published online as a Web First article today in Health Affairs and performed by researchers at The Lewin Group.

13 Jan 2010

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

13 Jan 2010

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced the completion of patient enrollment in its global Phase 3 clinical trial NEET (70971-004), which is evaluating the safety and efficacy of D-tagatose as an oral treatment for Type 2 diabetes mellitus.

12 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

Soccer-specific exercise program may prevent knee injuries in young female players

A soccer-specific exercise program that includes individual instruction of athletes appears to reduce the risk of knee injuries in young female players, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Jan 2010

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

Isis Pharmaceuticals, Inc. announced today that it has added a new drug, ISIS-APOCIIIRx, to its development pipeline. ISIS-APOCIIIRx provides a novel approach to treat hypertriglyceridemia, or high levels of triglycerides (TG).

12 Jan 2010

Yoga lowers number of compounds in blood and reduces inflammation

Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

12 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

King Center to host second annual 'Health and Wellness Forum'

The King Center announced that it will officially launch the 2010 MLK Birthday Observance on Saturday, Jan. 9, 2010 by hosting and co-sponsoring its second annual “Health and Wellness Forum.” It is being co-sponsored by a $50,000 grant from Aetna, which also funded last year’s inaugural program.

8 Jan 2010

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Contrary to the widely-held belief, there is no proof that non-insulin-dependent patients with type 2 diabetes benefit from glucose self-monitoring. Moreover, it remains unclear whether an additional benefit is displayed by the blood test compared to the urine test or vice versa, in other words, whether one or other of the tests might offer an advantage to patients.

8 Jan 2010

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.

8 Jan 2010

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

MAGIC investigators identify new genetic variants that influence insulin and glucose regulation

ASA urges patients to make lifestyle changes before opting for complicated surgeries

Researchers identify new gene variants associated With glucose, insulin levels

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

Researchers uncover novel genetic markers for diabetes-related traits

OSA adversely affects glucose control in patients with type 2 diabetes

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

New analysis finds cost of diabetes and pre-diabetes reached $218 billion in 2007

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Soccer-specific exercise program may prevent knee injuries in young female players

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

Yoga lowers number of compounds in blood and reduces inflammation

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

King Center to host second annual 'Health and Wellness Forum'

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in